Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1996-08-28
1998-01-13
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
4241481, 4241521, 4241721, A61K 3942
Patent
active
057076260
ABSTRACT:
Therapeutic strategies for the treatment of immunoinfective cluster virus infections in humans involving the use of antibodies or fragments thereof which are characteristic of autoantibodies produced by patients affected with systemic rheumatic disorders and cross-react with epitopes on an immunoinfective cluster virus. Additional therapeutic strategies include the use U1 RNA or fragments thereof to treat said viral infections.
REFERENCES:
patent: 2843889 (1958-01-01), Puri
patent: 5137805 (1992-08-01), Kingston et al.
Vittecoq et al., Proc. Nat'l. Acad. Sci., USA 92:1195-1199, Feb., 1995.
Ho, D.D., Science 272:1124-1125, 24 May 1996.
Mellors, et al., Science 272:1167-1170, 24 May 1996.
Fahey et al., "Status of Immune-based Therapies in HIV Infection and AIDS," Clin. Exp. Immunol. 88:1-5, 1992.
Fox, J.L., "No Winners Against AIDS", Bio/Technology 12:128, Feb. 1994.
Douvas et al. Cross-reactivity between Autoimmune Anti-U1 snRNP Abs. & Neutralizing Epitopes of HIV-1 gp120/41 Aids. Res. Hum. Retroviruses 10:253 1994.
Passive Immunization The Merck Index pp. 1948-1949 16th edition 1992.
Stein et al. Immune-based Therapeutics: Scientific Rationale and The Promising Approach to the Treatment of HIV Infected Individual Clin. Infect. Dis. 17:749, 1995.
Cronstein et al. The Adhesion Molecules of Inflammation Arthritis & Rheumatism 36:147 1993.
Buckley et al. The Use of Intravenous Immune Globulin in Immunodeficiency Diseases NEJM Jul. 11, 1991 pp. 110-117.
Ngou et al. Ab Responses Against Polypeptide Components of EDU Induced Early Diffuse Ag in Patients with MCTD J. Med Virol. 32:34, 1990.
Stiehm et al. Intravenous Igs as Therapeutic Agents Ann. Internal Med. 107:367, 1987.
Albrecht, M.A., et al., "The Herpes Simplex Virus Immediate--Early Protein, ICP4, Is Required To Potentiate Replication Of Human Immunodeficiency Virus In CD4+ Lymphocytes" J. Virol., vol. 63, No. 5, 1861-1868 (May 1989).
Bandziulis, R.J., et al., "RNA-Binding Proteins As Developmental Regulators" Genes & Devel., 3, 431-437 (1989).
Berget, S.M., et al., "U1, U2, And U4/U6 Small Nuclear Ribonucleoproteins Are Required For In Vitro Splicing But Not Polyadenylation" Cell, vol. 46, 691-696 (Aug. 29, 1986).
Bjorkman, P.J., et al., "The Foreign Antigen Binding Site And T Cell Recognition Regions Of Class 1 Histocompatibility Antigens" Nature, vol. 329, 512-518 (Oct. 8, 1987).
Black, D.L., et al., "U2 As Well As U1 Small Nuclear Ribonucleoprotein Are Involved In Premessenger RNA Splicing" Cell, vol. 42, 737-750 (Oct. 1985).
Boelens, W., et al., "Analysis Of In Vitro Binding Of U1-A Protein Mutants To U1 snRNA" Nuc. Acid Res., vol. 19, No. 17, 4611-4618 (1991).
Bringmann, P., et al., "Purification Of The Individual snRNPs U1, U2, U5 And U4/U6 From HeLa Cells And Characterization Of Their Protein Constituents" The EMBO Journal, vol. 5, No. 13, 3509-3516 (1986).
Broliden, P.A., et al., "Identification Of Human Neutralization-Inducing Regions Of The Human Immunodeficiency Virus Type 1 Envelope Glycoproteins" Proc. Natl. Acad. Sci. USA, vol. 89, 461-465 (Jan. 1992).
Calin, A., et al., "Genetic Differences Between B27 Positive Patients With Ankylosing Spondylitis And B27 Positive Healty Controls"Arthritis and Rheumatism, vol. 26, No. 12, 1460-1464 (Dec. 1983).
Chou, P.Y., et al., "Empirical Predictions Of Protein Conformation" Ann. Rev. Biochem., 47:251-76, 251-276 (1978).
Cram, D.S., et al., "Mapping Of Multiple B Cell Epitopes On The 70-Kilodalton Autoantigen Of The U1 Ribonucleoprotein Complex" J. Immunol. vol. 145, No. 2, 630-635 (Jul. 15, 1990).
Crow, M.K., et al., "Human Peripheral Blood T Helper Cell-Induced B Cell Activation Results In B Cell Surface Expression Of The CD23 (BLAST-2) Antigen" Cell. Immunol., 121, 99-112 (1989).
Devereux, J., et al., "A Comprehensive Set Of Sequence Analysis Programs For The VAX" Nuc. Acid Res., vol. 12, No. 1, 387-395 (1984).
Douvas, A., et al., "Multiple Overlapping Homologies Between Two Rheumatoid Antigens And Immunosuppressive Viruses" Proc. Natl. Acad. Sci. USA, vol. 88, 6328-6332 (Jul. 1991).
Douvas, A.S., et al., "Isolation And Characterization Of Nuclear Ribonucleoprotein Complexes Using Human Anti-Nuclear Ribonucleoprotein Antibodies" J. Biol. Chem., vol. 254, No. 9, 3608-3616 (May 10, 1979).
Douvas, A.S., "Autoantibodies Occuring In Two Different Theumatic Diseases React With The Same Nuclear Ribonucleoprotein Particle" Proc. Natl. Acad. Sci. USA, vol. 79, 5401-5405 (Sep. 1982).
Dower, S.K., et al., "Phosphorus-31 Nuclear Magnetic Resonance Probes For The Combining Site Of The Myeloma Protein M315" Biochem., vol. 18, No. 17, 3668-3674 (1979).
Durda, P.J., et al., "HIV-1 Neutralizing Monoclonal Antibodies Induced By A Synthetic Peptide" AIDS Res. Hum. Retro., vol. 6, No. 9, 1115-1123 (1990).
Earnshaw, W.C., et al., "Molecular Cloning Of cDNA For CENP-B, The Major Human Centromere Autoantigen" J. Cell. Biol., 104, 817-829 (1987).
Emini, E.A., et al., "Induction Of Hepatitis A Virus-Neutralizing Antibody By A Virus-Specific Synthetic Peptide" J. Virol., vol. 55, No. 3, 836-839 (Sep. 1985).
Ewing, C., et al., "Antibody Activity In Ankylosing Spondylitis Sera To Two Sites On HLA B27.1 At The MHC Groove Region (Within Sequence 65-85), And To A Klebsiella Pneumoniae Nitrogenase Reductase Peptide (Within Sequence 181-199)" J.Exp. Med., vol. 171, 1635-1647 (May 1990).
Fox, R., "Epstein-Barr Virus And Human Autoimmune Diseases: Posibilities And Pitfalls" J. Virol. Meth., 21, 19-27 (1988).
Fox, R., et al., "Potential Role Of Epstein-Barr Virus In Sjogren's Syndrome" Rheumatic Disease Clinics of North America, vol. 13, No. 2, 275-292 (Aug. 1987).
Gimble, J.M., et al., "Activation Of The Human Immunodeficiency Virus Long Terminal Repeat By Herpes Simplex Virus Type 1 Is Associated With Induction Of A Nuclear Factor That Binds To The NF-.kappa.B/Core Enhancer Sequence" J. Virol., vol. 62, 4104-4112 (Nov. 1988).
Girard, M., et al., "Immunization Of Chimpanzees Confers Protection Against Challenge With Human Immunodeficiency Virus" Proc. Natl. Acad. Sci. USA, vol. 88, 542-546 (Jan. 1991).
Glockshuber, R., et al., "A Comparison Of Strategies To Stabilize Immunoglobulin F.sub.v -Fragments" Biochem., 29, 1362-1367 (1990).
Goudsmit, J., et al., "Human Immunodeficiency Virus Type 1 Neutralization Epitope With Conserved Architecture Elicits Early Type-Specific Antibodies In Experimentally Infected Chimpanzees" Proc. Natl. Acad. Sci. USA vol. 85, 4478-4482 (Jun. 1988).
Guldner, H.H., et al., "Epitope Mapping With A Recombinant Human 68-kDa (U1) Ribonucleoprotein Antigen Reveals Heterogenous Autoantibody Profiles In Human Autoimmune Sera" J.Immunol., vol. 141, No. 2, 469-475 (Jul. 15, 1988).
Guldner, H.H., et al., "Human Anti-P68 Autoantibodies Recognize A Common Epitope Of U1 RNA Containing Small Nuclear Ribonucleoprotein And Influenza B Virus" J. Exp. Med., vol. 171, 819-829 (Mar. 1990).
Gussow, D., et al., "Humanization Of Monoclonal Antibodies" Methods Enzymol., vol. 203, 99-121 (1991).
Habeshaw, J.A., et al., "AIDS Pathogenesis: HIV Envelope And Its Interaction With Cell Proteins" Immunol. Today, 11, 418-425 (1991).
Hamm, J., et al., "In Vitro Assembly Of U1 snRNPs" EMBO J., vol. 6, 3479-3485 (1987).
Hamm, J., et al., "Loop I Of U1 Small Nuclear RNA Is The Only Essential RNA Sequence For Binding Of Specific U1 Small Nuclear Ribonucleoprotein Particle Proteins" Mol. Cell. Biol., vol. 8, No. 11, 4787-4791 (Nov. 1988).
Harbers, M., et al., "Suppression Of c-fos Precursor RNA Splicing By The Protein Kinase C Inhibitor H7 (1991).
Hilvert, D., et al., "Antibody Catalysis Of Concerted, Carbon--Carbon Bond-Forming Reactions" Methods Enzymol., vol. 203, 352-369 (1991).
Hockensmith, J.W., et al., "Laser Cross-Linking Of Nucleic Acids To Proteins" J. Biol. Chem., vol. 261, No. 8, 3512-3518 (Mar. 15, 1986).
Huston, J.S., et al., "Protein Engineering Of Antibody Binding Sites: Recovery Of Specific Activity In An Anti-Digoxin Single-Chain Fv Analogue Produced In Escherichia coli" Proc. Natl. Acad. Sci. USA, vol. 85, 5879-5883 (Aug. 1988).
Huston, J.S., et al., "Protein Engineering Of Single-Chain Fv Analogs
Douvas Angeline
Ehresmann Glenn
Takehana Yoshi
Budens Robert D.
University of Southern California
LandOfFree
Methods of treating HIV infection using antibodies to the U2 sma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating HIV infection using antibodies to the U2 sma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating HIV infection using antibodies to the U2 sma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-324084